Dérivés de (4-tert-butylpiperazine-2-yl)(pipérazine-1-yl)méthanone-N-carboxamide
- 专利权人:
- Astrazeneca AB
- 发明人:
- 申请号：
- EP14153398.4
- 公开号：
- EP2727913A1
- 申请日:
- 2009.12.14
- 申请国别(地区):
- EP
- 年份:
- 2014
- 代理人:
- 摘要：
- The present invention relates to compounds of formula (I)The compounds act via antagonism of the CCR2b receptor and may be used to treat inflammatory disease and/or neuropathic pain.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- DÉRIVÉS DU (4-TERT-BUTYLPIPÉRAZIN-2-YL)(PIPÉRAZIN-1-YL)MÉTHANONE-N-CARBOXAMIDE
- (4-TERT-BUTYLPIPERAZIN-2-YL)(PIPERAZIN-1-YL)METHANONE-N-CARBOXAMIDE DERIVATIVES
- (4-tert-butylpiperazin-2-yl)(piperazin-1-yl)methanone-N-carboxamide derivatives
- (4-TERT-BUTYLPIPERAZIN-2-YL)(PIPERAZIN-1-YL)METHANONE-N-CARBOXAMIDE DERIVATIVES
- (4-TERT-BUTYLPIPERAZIN-2-YL)(PIPERAZIN-1-YL)METHANONE-N-CARBOXAMIDE DERIVATIVES
